DR info

Clinical trials : 41 / Drugs : 46 - (DrugBank : 9) / Drug target genes : 11 - Drug target pathways : 15

Charcot-Marie-Tooth disease and other diseases between which drug repositioning might occur (Sakate and Kimura 2021) . Circle size: Number of drugs, Line breadth: Drug repositionability

ID	Diseases (Sorted by drug repositionability)
10	Charcot-Marie-Tooth disease
13	Multiple sclerosis/Neuromyelitis optica
46	Malignant rheumatoid arthritis
231	Alpha-1-antitrypsin deficiency
298	Hereditary pancreatitis
226	Interstitial cystitis with Hunners ulcer
70	Spinal stenosis
51	Scleroderma
97	Ulcerative colitis
96	Crohn disease
6	Parkinson disease
2	Amyotrophic lateral sclerosis
168	Ehlers-Danlos syndrome
1	Spinal and bulbar muscular atrophy
36	Epidermolysis bullosa
86	Pulmonary arterial hypertension
38	Stevens-Johnson syndrome
114	Non-dystrophic myotonia syndrome
256	Muscle glycogenosis
127	Frontotemporal lobar degeneration
58	Hypertrophic cardiomyopathy
140	Dorabe syndrome
144	Lennox-Gastaut syndrome
193	Prader-Willi syndrome
107	Juvenile idiopathic arthritis
53	Sjogren syndrome
113	Muscular dystrophy
28	Systemic amyloidosis
156	Rett syndrome
84	Sarcoidosis
8	Huntington disease
34	Neurofibromatosis
149	Hemiconvulsion hemiplegia epilepsy syndrome
43	Microscopic polyangiitis
45	Eosinophilic granulomatosis with Polyangiitis
44	Wegener granulomatosis
40	Takayasu arteritis
42	Polyarteritis nodosa
41	Giant cell arteritis